NEW TARGETS MODULATED BY A CASUAL VARIANT OF TYPE 2 DIABETES (T2D) EMBEDDED WITHIN THE TCF7L2 GENE AND METHODS OF USE THEREOF FOR IDENTIFYING AGENTS HAVING EFFICACY FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER METABOLIC DISORDERS
JOHNSON, Matthew, E.,XIA, Qianghua,JOHNSTON, Brian, T.,CHESI, Alessandra,GRANT, Struan, F. A.
申请号：
USUS2016/037242
公开号：
WO2016/201438A1
申请日:
2016.06.13
申请国别(地区):
WO
年份:
2016
代理人:
摘要：
Compositions and methods are provided which modulate the enhancer/silencer function embedded within TCF7L2 for treating metabolic disease including T2D are disclosed.Linvention concerne des compositions et des procédés qui modulent la fonction activateur/silenceur intégrée dans TCF7L2 pour le traitement dune maladie métabolique, notamment le T2D.
